Log in

Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration

  • Research
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Exenteration surgery for multi-visceral pelvic malignancy is a complex life-changing operation with high perioperative morbidity and mortality. Traditional open surgery has long been the standard approach for pelvic exenteration for achieving Ro resection which is the main aim of surgery. In the current era of minimally invasive surgery, robotic-assisted pelvic exenteration has provided a promising alternative, offering potential advantages in terms of improved oncological outcomes and enhanced postoperative recovery. This study aims to explore the feasibility of a robotic platform for locally advanced multi-visceral pelvic malignancy.

Methods

A retrospective review from the prospectively maintained robotic colorectal surgery database at University Hospital Coventry and Warwickshire (UHCW) Trust was performed. Demographic details and clinical and surgical details were documented from the case records. Data was analysed using SPSS version 22.

Results

Thirteen female patients diagnosed with primary or recurrent pelvic malignancy who underwent robotic pelvic exenteration at UHCW between February 2019 and April 2023 at UHCW were included. The mean age of our patients was 60.4 (± 10.1) years. Complete Ro resection was achieved in all 13 (100%) cases on final histopathology. The median length of hospital stay was 15 days after this extensive surgery. Grade 3 morbidity on Clavien–Dindo classification was observed in four (30.7%) patients, while zero percent 30-day mortality was experienced in this study. At a median follow-up of 21 (3–53) months, we observed tumor recurrence in three (23.7%) patients, while death in four (30.7%) patients. Only few studies have highlighted outcomes of robotic pelvic exenteration, and our results were quite comparable to them.

Conclusion

Robotic-assisted pelvic exenteration for primary or recurrent pelvic malignancy is feasible with improved oncological and acceptable postoperative outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ASA :

American Society of Anesthesiologists

DS :

Disease-free survival

OS :

Overall survival

MDT :

Multidisciplinary meeting

SPSS :

Statistical Package for the Social Sciences

UHCW :

University Hospital Coventry and Warwickshire

References

  1. Butcher HR Jr, Spjut HJ (1959) An evaluation of pelvic exenteration for advanced carcinoma of the lower colon. Cancer 12(4):681–687

    Article  PubMed  Google Scholar 

  2. Shin US, Nancy You Y, Nguyen AT, Bednarski BK, Messick C, Maru DM et al (2016) Oncologic outcomes of extended robotic resection for rectal cancer. Ann Surg Oncol 23:2249–2257

    Article  PubMed  Google Scholar 

  3. Temple WJ, Ketcham AS (1982) The closure of large pelvic defects by extended compound tensor fascia lata and inferior gluteal myocutaneous flaps. Am J Clin Oncol 5(6):573–578

    Article  PubMed  CAS  Google Scholar 

  4. PelvEx Collaborative (2019) Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer. BJS Open 3(4):516–520.  https://doi.org/10.1002/bjs5.50153

  5. Saqib SU, Raza MZ, Evans C, Bajwa AA (2023) The robotic learning curve for a newly appointed colorectal surgeon. J Robot Surg 17(1):73–78

    PubMed  Google Scholar 

  6. Chang TP, Chok AY, Tan D, Rogers A, Rasheed S, Tekkis P et al (2021) The emerging role of robotics in pelvic exenteration surgery for locally advanced rectal cancer: a narrative review. J Clin Med 10(7):1518

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nanayakkara P, Ahmed S, Oudit D, O’Dwyer S, Selvasekar C (2014) Robotic assisted minimally invasive pelvic exenteration in advanced rectal cancer: review and case report. J Robot Surg 8:173–175

    Article  PubMed  CAS  Google Scholar 

  8. Steele SR, Maykel JA, Lightner AL, Bleier JI (2022) Steele’s colon and rectal surgery. In: Multivisceral and management of recurrent colorectal cancer. Wolters Kluwer Health, p 460

  9. Guru KA, Nogueira M, Piacente P, Nyquist J, Mohler JL, Kim HL (2007) Rapid communication: robot-assisted anterior exenteration: technique and initial series. J Endourol 21(6):633–639

    Article  PubMed  Google Scholar 

  10. Lim PC (2009) Robotic assisted total pelvic exenteration: a case report. Gynecol Oncol 115(2):310–311

    Article  PubMed  Google Scholar 

  11. Shin J, Kim J, Kwak J, Hara M, Cheon J, Kang S et al (2014) First report: robotic pelvic exenteration for locally advanced rectal cancer. Colorectal Dis 16(1):O9–O14

    Article  PubMed  CAS  Google Scholar 

  12. Williams M, Perera M, Nouhaud F-X, Coughlin G (2021) Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy. Investig Clin Urol 62(1):111

    Article  PubMed  Google Scholar 

  13. Kroon HM, Dudi-Venkata N, Bedrikovetski S, Thomas M, Kelly M, Aalbers A et al (2019) Palliative pelvic exenteration: a systematic review of patient-centered outcomes. Eur J Surg Oncol 45(10):1787–1795

    Article  Google Scholar 

  14. Quyn AJ, Solomon MJ, Lee PM, Badgery-Parker T, Masya LM, Young JM (2016) Palliative pelvic exenteration: clinical outcomes and quality of life. Dis Colon Rectum 59(11):1005–1010

    Article  PubMed  Google Scholar 

  15. Larach JT, Flynn J, Fernando D, Mohan H, Rajkomar A, Waters PS et al (2022) Robotic beyond total mesorectal excision surgery for primary and recurrent pelvic malignancy: feasibility and short-term outcomes. Colorectal Dis 24(7):821–827

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by S.S. and Z.R. Data analysis was performed by S.S. The first draft of the manuscript was written by S.S., later amended by Z.R. J.T., O.A., and A.B. were robotic surgeons involved in care of patients and did the final editing. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sabah Uddin Saqib.

Ethics declarations

Ethical approval

Not required as data was collected from files and patients were not directly involved.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saqib, S.U., Raza, M.Z., Twigg, J. et al. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration. Langenbecks Arch Surg 409, 9 (2024). https://doi.org/10.1007/s00423-023-03206-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00423-023-03206-7

Keywords

Navigation